The effects of aging on dopaminergic neurotransmission: A microPET study of [11C]-raclopride binding in the aged rodent brain

E. Hoekzema, R. Herance, S. Rojas, D. Pareto, S. Abad, X. Jiménez, F. P. Figueiras, F. Popota, A. Ruiz, Torrent, F. J. Fernández-Soriano, M. Rocha, M. Rovira, V. M. Víctor, J. D. Gispert

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Scopus)

Abstract

Rodent models are frequently used in aging research to investigate biochemical age effects and aid in the development of therapies for pathological and non-pathological age-related degenerative processes. In order to validate the use of animal models in aging research and pave the way for longitudinal intervention-based animal studies, the consistency of cerebral aging processes across species needs to be evaluated. The dopaminergic system seems particularly susceptible to the aging process, and one of the most consistent findings in human brain aging research is a decline in striatal D2-like receptor (D2R) availability, quantifiable by positron emission tomography (PET) imaging. In this study, we aimed to assess whether similar age effects can be discerned in rat brains, using in vivo molecular imaging with the radioactive compound [11C]-raclopride. We observed a robust decline in striatal [11C]-raclopride uptake in the aged rats in comparison to the young control group, comprising a 41% decrement in striatal binding potential. In accordance with human studies, these results indicate that substantial reductions in D2R availability can be measured in the aged striatal complex. Our findings suggest that rat and human brains exhibit similar biochemical alterations with age in the striatal dopaminergic system, providing support for the pertinence of rodent models in aging research. © 2010 IBRO.
Original languageEnglish
Pages (from-to)1283-1286
JournalNeuroscience
Volume171
Issue number4
DOIs
Publication statusPublished - 29 Dec 2010
Externally publishedYes

Cite this